These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32566150)

  • 41. China's counterfeit medicine trade booming.
    Lewis K
    CMAJ; 2009 Nov; 181(10):E237-8. PubMed ID: 19805500
    [No Abstract]   [Full Text] [Related]  

  • 42. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
    Fine A
    Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
    [No Abstract]   [Full Text] [Related]  

  • 43. [Rising attention to the market to ratio meet demand of improving efficiency of pharmaceutical circulation--based on complicated variety and specification of drugs].
    Chen Z; Sun L
    Zhongguo Zhong Yao Za Zhi; 2010 May; 35(10):1357-60. PubMed ID: 20707215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacy benefit managers and their obligations during serious prescription drug shortages.
    Teagarden JR; Epstein RS
    Clin Pharmacol Ther; 2013 Feb; 93(2):143-5. PubMed ID: 23337523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.
    Clay P; Vaught E; Glaros A; Mangum S; Hansen D; Lindsey C
    J Manag Care Pharm; 2007; 13(6):506-14. PubMed ID: 17672812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reimportation of pharmaceuticals: economic and policy implications. Proceedings from an internet presentation, October 29-31, 2003.
    Manag Care; 2004 Mar; 13(3 Suppl):1-44. PubMed ID: 15137376
    [No Abstract]   [Full Text] [Related]  

  • 47. At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products.
    Varmaghani M; Heidari E; Reiner Ž; Sahebkar A
    J Med Econ; 2020 Oct; 23(10):1193-1195. PubMed ID: 32580595
    [No Abstract]   [Full Text] [Related]  

  • 48. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of quality, capacity, and productivity at Merck.
    Nathan J; Venkataraman R
    Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Success of ophthalmic pharmaceutical start-up companies.
    Stewart WC; Kruft B; Nelson LA; Stewart JA
    Acta Ophthalmol; 2018 Mar; 96(2):e266-e268. PubMed ID: 29068525
    [No Abstract]   [Full Text] [Related]  

  • 51. A multidimensional framework for specialty drug management.
    Bell GK; Baumann SA
    Manag Care; 2013 Mar; 22(3):30-5. PubMed ID: 23610804
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug shortages in the United States: a critical evaluation of root causes and the need for action.
    Gupta DK; Huang SM
    Clin Pharmacol Ther; 2013 Feb; 93(2):133-5. PubMed ID: 23337520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Achieving a quality drug supply.
    Nelson G
    J Am Pharm Assoc; 1974 Oct; 14(10):548-9, 564. PubMed ID: 4420394
    [No Abstract]   [Full Text] [Related]  

  • 55. Summary of the second executive session on emergency preparedness and the pharmaceutical supply chain.
    Am J Health Syst Pharm; 2002 Jun; 59(11):1057-65. PubMed ID: 12063891
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug industry is considering more use of differential pricing, conference hears.
    Sukkar E
    BMJ; 2011 Dec; 343():d8049. PubMed ID: 22155726
    [No Abstract]   [Full Text] [Related]  

  • 57. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 59. EU agrees deal on cheaper drugs for developing world.
    Watson R
    BMJ; 2003 Jun; 326(7401):1229. PubMed ID: 12791716
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.
    Hasan SS; Kow CS; Dawoud D; Mohamed O; Baines D; Babar ZU
    Value Health Reg Issues; 2019 May; 18():18-23. PubMed ID: 30414506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.